Internal Medicine, Hematology & Oncology · Jacksonville, NC
NPI
1740466564
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
239 Station Street
Jacksonville, NC, 28546
Phone (910) 353-0819
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
308,649 services
Medicare patients, 2024
969
Average age 73
Drug cost, 2024
$6.3M
2,750 prescriptions
Company payments, 2025
$2,700
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nagesh H Jayaram was code J1439 (injection, ferric carboxymaltose, 1 mg), 81,000 times for 63 patients. In total Nagesh H Jayaram billed 308,649 services in 146 codes, and Medicare paid $3.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 81,000 | 63 | $0.87 | $70K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 52,530 | 59 | $0.28 | $15K |
| J0897 Injection, denosumab, 1 mg | Office | 11,763 | 70 | $19.95 | $235K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,400 | 22 | $0.11 | $1,238 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 11,304 | 11 | $2.31 | $26K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,100 | 31 | $14.56 | $45K |
| J3480 Injection, potassium chloride, per 2 meq | Office | 3,095 | 19 | $0.09 | $268 |
| 85025 Blood Count | Office | 2,818 | 772 | $7.55 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,524 | 56 | $0.09 | $219 |
| 36415 Venipuncture Blood Collection | Office | 2,060 | 734 | $7.83 | $16K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,700 | 41 | $0.68 | $1,160 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 1,514 | 18 | $0.43 | $647 |
| 80053 Clinical Chemistry | Office | 1,315 | 334 | $10.23 | $13K |
| 99214 Office E&M - Established | Office | 749 | 429 | $92.98 | $70K |
| 96367 Intravenous Infusion, Hydration | Office | 706 | 95 | $22.36 | $16K |
By year: 2022 $4.3M for 380,247 services; 2023 $3.8M for 286,855 services; 2024 $3.4M for 308,649 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,818 | 772 | $7.55 | $21K |
| 36415 Venipuncture Blood Collection | 2,060 | 734 | $7.83 | $16K |
| 80053 Clinical Chemistry | 1,315 | 334 | $10.23 | $13K |
| 83735 Clinical Chemistry | 417 | 58 | $6.41 | $2,674 |
| 81001 Clinical Chemistry | 87 | 26 | $3.11 | $271 |
| 85610 Clinical Chemistry | 57 | 11 | $4.07 | $232 |
Medicare prescription drug claims, 2024
In 2024, the drug Nagesh H Jayaram prescribed most often to Medicare patients was Oxycodone Hcl, with 174 prescriptions and refills. In total Nagesh H Jayaram wrote 2,750 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 174 | 174 | 43 | $2,814 |
| Letrozole Generic | 156 | 289 | 41 | $2,607 |
| Potassium Chloride Generic | 84 | 93 | 33 | $469 |
| Warfarin Sodium Generic | 74 | 120 | Under 11 | $285 |
| Lenalidomide Generic | 69 | 69 | 12 | $1.2M |
| Xarelto Rivaroxaban | 64 | 80 | 11 | $44K |
| Omeprazole Generic | 57 | 81 | 14 | $588 |
| Trazodone Hcl Generic | 55 | 55 | 16 | $143 |
| Eliquis Apixaban | 53 | 68 | 11 | $37K |
| Ondansetron Hcl Generic | 50 | 51 | 33 | $1,050 |
| Pantoprazole Sodium Generic | 49 | 49 | 11 | $157 |
| Levothyroxine Sodium Generic | 49 | 62 | 14 | $341 |
| Montelukast Sodium Generic | 46 | 46 | Under 11 | $134 |
| Xtandi Enzalutamide | 46 | 46 | Under 11 | $641K |
| Promethazine Hcl Generic | 44 | 46 | 23 | $740 |
Brand drugs: - claims; generic drugs: 2,033 claims; opioid claims: 312.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nagesh H Jayaram $2,700 ($2,700 in general payments such as food, travel and fees) from 44 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,215.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 17 | $1,215 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $108 |
| Merck Sharp & Dohme LLC MRK | 3 | $86.27 |
| Celgene Corporation BMY | 4 | $79.44 |
| Daiichi Sankyo Inc. 4568.T | 3 | $74.26 |
| Abbvie Inc. ABBV | 3 | $53.62 |
| TerSera Therapeutics LLC | 2 | $50.34 |
| Aveo Pharmaceuticals, Inc. | 2 | $49.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $48.44 |
| Array Biopharma Inc PFE | 3 | $47.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.